ロード中...
Changing Times for CLN2 Disease: The Era of Enzyme Replacement Therapy
Neuronal ceroid lipofuscinosis type 2 (CLN2 disease) is a progressive neurodegenerative disease that results in early-onset, severe, progressive, neurological disabilities, leading to death in late childhood or early adolescence. Management has relied on symptomatic care, and supportive and palliati...
保存先:
| 出版年: | Ther Clin Risk Manag |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7127909/ https://ncbi.nlm.nih.gov/pubmed/32280231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S241048 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|